Literature DB >> 2820961

Receptor-mediated endocytosis of lactate dehydrogenase M4 by liver macrophages: a mechanism for elimination of enzymes from plasma. Evidence for competition by creatine kinase MM, adenylate kinase, malate, and alcohol dehydrogenase.

M J Smit1, A M Duursma, J M Bouma, M Gruber.   

Abstract

We have previously shown that the rapid clearance of intravenously injected lactate dehydrogenase M4 from plasma is mainly due to endocytosis by macrophages in liver, spleen, and bone marrow. We have now studied endocytosis of lactate dehydrogenase M4 in detail, using freshly isolated rat liver macrophages (Kupffer cells) in vitro. 125I-lactate dehydrogenase M4 rapidly accumulated in the cells and was subsequently degraded to trichloroacetic acid-soluble material. Degradation was inhibited by leupeptin, an inhibitor of lysosomal proteases. Breakdown of the protein was also greatly diminished by treatment of the cells with chloroquine, a weak base which inhibits proteolysis by raising the pH in endosomes and lysosomes. High concentrations of chloroquine inhibited uptake. Lactate dehydrogenase M4 was not endocytosed by liver endothelial cells, although, under the same conditions, these cells were shown to accumulate horse radish peroxidase via a mannose-specific receptor. Uptake of lactate dehydrogenase M4 by Kupffer cells was strongly reduced after pretreatment of the cells with low concentrations of proteases. Endocytosis of lactate dehydrogenase M4 exhibited saturation kinetics (Km = 0.8 microM) and was competitively inhibited by mitochondrial and cytosolic malate dehydrogenase, alcohol dehydrogenase, adenylate kinase, and creatine kinase MM, enzymes which are rapidly cleared in vivo. Enzymes with long half-lives in plasma, namely lactate dehydrogenase H4, alanine aminotransferase, and cytosolic aspartate aminotransferase did not compete at concentrations up to 10 microM. Our results indicate that Kupffer cells contain a receptor that is involved in the clearance of lactate dehydrogenase M4 and a number of other tissue-derived enzymes from plasma. Uptake of lactate dehydrogenase M4 does not occur via a receptor that recognizes carbohydrate residues, for the enzyme is not a glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820961

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Enhanced clearance of lactic dehydrogenase-5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance.

Authors:  T Hayashi; M Ozaki; I Mori; M Saito; T Itoh; H Yamamoto
Journal:  Int J Exp Pathol       Date:  1992-04       Impact factor: 1.925

Review 2.  Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.

Authors:  Bin Shi; Marc Abrams
Journal:  J Histochem Cytochem       Date:  2013-03-14       Impact factor: 2.479

3.  Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.

Authors:  Bin Shi; Ed Keough; Andrea Matter; Karen Leander; Stephanie Young; Ed Carlini; Alan B Sachs; Weikang Tao; Marc Abrams; Bonnie Howell; Laura Sepp-Lorenzino
Journal:  J Histochem Cytochem       Date:  2011-08       Impact factor: 2.479

4.  Increased serum enzyme levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury.

Authors:  Zaher A Radi; Petra H Koza-Taylor; Rosonald R Bell; Leslie A Obert; Herbert A Runnels; Jean S Beebe; Michael P Lawton; Seth Sadis
Journal:  Am J Pathol       Date:  2011-05-13       Impact factor: 4.307

5.  Clearance of LDH-5 from the circulation of inbred mice correlates with binding to macrophages.

Authors:  T Hayashi; A L Notkins
Journal:  Int J Exp Pathol       Date:  1994-06       Impact factor: 1.925

6.  A mechanistic model of drug-induced liver injury AIDS the interpretation of elevated liver transaminase levels in a phase I clinical trial.

Authors:  B A Howell; S Q Siler; L K M Shoda; Y Yang; J L Woodhead; P B Watkins
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-02-05

7.  Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials.

Authors:  D M Longo; G T Generaux; B A Howell; S Q Siler; D J Antoine; D Button; A Caggiano; A Eisen; J Iaci; R Stanulis; T Parry; M Mosedale; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  2017-05-27       Impact factor: 6.875

8.  Common and rare variants associating with serum levels of creatine kinase and lactate dehydrogenase.

Authors:  Ragnar P Kristjansson; Asmundur Oddsson; Hannes Helgason; Gardar Sveinbjornsson; Gudny A Arnadottir; Brynjar O Jensson; Aslaug Jonasdottir; Adalbjorg Jonasdottir; G Bragi Walters; Gerald Sulem; Arna Oskarsdottir; Stefania Benonisdottir; Olafur B Davidsson; Gisli Masson; Olafur Th Magnusson; Hilma Holm; Olof Sigurdardottir; Ingileif Jonsdottir; Gudmundur I Eyjolfsson; Isleifur Olafsson; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Patrick Sulem; Kari Stefansson
Journal:  Nat Commun       Date:  2016-02-03       Impact factor: 14.919

Review 9.  Methods for Isolation and Purification of Murine Liver Sinusoidal Endothelial Cells: A Systematic Review.

Authors:  Jeremy Meyer; Carmen Gonelle-Gispert; Philippe Morel; Léo Bühler
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

Review 10.  Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses.

Authors:  P G Plagemann; V Moennig
Journal:  Adv Virus Res       Date:  1992       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.